Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

GlaxoSmithKline Inc. Recalls Several Lots of Ventolin HFA (Albuterol Sulfate) 90 mcg
GlaxoSmithKline Inc. has recalled several lots of Ventolin HFA (albuterol sulfate) 90 mcg, 60 actuations per inhaler. The following lot numbers have been recalled because the product in these lots may not deliver all 60 inhalations: 1ZP0922, 1ZP0571, 1ZP6915, 1ZP6939, 1ZP7823, 1ZP8151, 1ZP0856, 1ZP1981, 1ZP6941, 1ZP7824, 1ZP9063, 1ZP1061, 1ZP6940 and 1ZP9680. Ventolin HFA contains the active ingredient albuterol sulfate and is commonly used in the treatment of asthma. Albuterol sulfate is also sold under other brand names. This recall alert only applies to the select lots of Ventolin HFA (albuterol sulfate) 90 mcg, 60 actuations per inhaler. No other albuterol sulfate products were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm294071.htm
Learn More

Sandoz Inc. Recalls Select Lots of Cefprozil Powder for Oral Suspension, USP 125 mg/5 mL and 250 mg/5 mL
Sandoz Inc. has recalled several lots of Cefprozil Powder for Oral Suspension, USP 125 mg/5 mL and 250 mg/5 mL. The following lot numbers have been recalled because the products in these lots were not made in accordance with manufacturing standards: Cefprozil Powder for Oral Suspension, USP 125 mg/5 mL: Lots BX3481 and BX3483 Cefprozil Powder for Oral Suspension, USP 250 mg/5 mL: Lot BX3670 Cefprozil is used in the treatment of infection. Cefprozil is also sold under the brand name Cefzil. No other lots, strengths, or brands of Cefprozil were involved in this recall. To view the FDA notice about this recall, please visit: http://www.fda.gov/Safety/Recalls/EnforcementReports/ucm294071.htm
Learn More

Date Published Title Drug Source
2012-03-07 GlaxoSmithKline Inc. Recalls Several Lots of Ventolin HFA (Albuterol Sulfate) 90 mcg Albuterol FDA
2012-03-07 Sandoz Inc. Recalls Select Lots of Cefprozil Powder for Oral Suspension, USP 125 mg/5 mL and 250 mg/5 mL Cefprozil FDA
2012-03-05 New Jersey CVS Pharmacy Dispenses Breast Cancer Medicine Instead of Kids' Fluoride Tablets Sodium Fluoride MediGuard CRT
2012-03-02 FDA Warns about Drug Interaction - Taking Both Statins and HIV or Hepatitis C Drugs Increases Risk of Muscle Injury Indinavir FDA
2012-02-29 Prevnar Vaccine Recall Unlikely to Pose Health Risk Pneumococcal Conjugate Vaccine FDA
2012-02-29 GlaxoSmithKline Recalls All Lots of DynaCirc CR (Isradipine) Tablets Isradipine Manufacturer
2012-02-29 New Study Suggests Sleeping Pills May Raise Risk of Death Eszopiclone MediGuard CRT
2012-02-28 FDA Revises Dose Limitations for Lovastatin (Mevacor) and Lovastatin/Niacin (Advicor) Lovastatin FDA
2012-02-28 FDA Provides Safety Advice for Statins Atorvastatin FDA
2012-02-27 Glenmark Generics Recalls Birth Control Pills Due To Packaging Error that May Increase Risk of Unintended Pregnancies Ethinylestradiol with Norgestimate FDA
2012-02-26 FDA Issues Consumer Update about Grapefruit Juice and Medicine Interactions Cyclosporine FDA
2012-02-22 McNeil Consumer Healthcare Announces Recall of Infants’ TYLENOL Oral Suspension, 1 oz. Grape Due to Dosing System Complaints Manufacturer
2012-02-22 McNeil Consumer Healthcare Announces Recall of Infants’ TYLENOL Oral Suspension, 1 oz. Grape Due to Dosing System Complaints Acetaminophen Manufacturer
2012-02-19 McNeil Consumer Healthcare Announces Recall of Infants’ TYLENOL Oral Suspension, 1 oz. Grape Due to Dosing System Complaints Manufacturer
2012-02-17 Healthcare Professionals Advised That a Single Batch Of Clexane Syringe Needle Caps May Be Difficult To Remove Lovenox MHRA
2012-02-16 FDA Says Midodrine Will Continue to Be Available While Additional Studies Are Conducted Midodrine Hydrochloride FDA
2012-02-16 FDA and Manufacturers Warn about Conterfeit Avastin (Bevacizumab) Bevacizumab FDA
2012-02-13 FDA Issues Warning about Important Drug Interactions Between Victrelis (boceprevir) and Ritonavir-boosted Human Immunodeficiency Virus (HIV) Protease Inhibitors Lopinavir with Ritonavir FDA
2012-02-08 FDA Issues Safety Announcement: Proton Pump Inhibitors (PPIs) Possibly Associated with Clostridium Difficile-Associated Diarrhea (CDAD) Dexlansoprazole FDA
2012-02-02 Teva Pharmaceuticals USA, Inc Recalls Select Lots of Tetracycline Capsules 500 mg Tetracycline FDA